MARVEL BIOSCIENCES CORP (MRVL.CA) Stock Income Statement
Canada - TSX Venture Exchange - TSX-V:MRVL - CA57384M1077 - Common Stock
0.135 CAD
-0.01 (-6.9%)
| TTM (2025-10-31) | 2025 (2025-7-31) | 2024 (2024-7-31) | 2023 (2023-7-31) | 2022 (2022-7-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | N/A | 0.00 | |||
| Operating Expenses | 1.58M | 1.55M | 1.27M | 2.38M | 2.55M | |||
| Research and Development | 593.50K | 547.40K | 302.00K | 887.50K | 1.38M | |||
| Selling, General, and Administrative Expenses | 986.60K | 1.00M | 969.90K | 1.49M | 1.17M | |||
| Operating Income | -1.58M | -1.55M | -1.27M | -2.38M | -2.55M | |||
| Interest Income/Expense | -323.10K | -290.50K | -168.20K | -39.40K | -4.30K | |||
| Other Income/Expense | N/A | -372.30K | -210.00K | 126.20K | 0.00 | |||
| Income Before Taxes | -2.28M | -2.21M | -1.65M | -2.29M | -2.55M | |||
| Net Income | -2.28M | -2.21M | -1.65M | -2.29M | -2.55M | |||
| EBITDA | N/A | N/A | N/A | N/A | -2.55M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.04 | -0.05 | -0.04 | -0.06 | -0.08 | |||
| Statistics | ||||||||
All data in CAD